BRIEF published on 09/26/2024 at 12:35, 1 month 24 days ago SCHOTT Pharma, Gerresheimer et le groupe Stevanato forment une « alliance pour la RTU » Efficacité Pharmaceutique Confinement Des Drogues Alliance RTU Risque Opérationnel Emballage Stérile
BRIEF published on 09/26/2024 at 12:35, 1 month 24 days ago SCHOTT Pharma, Gerresheimer, and Stevanato Group Form “Alliance for RTU” Drug Containment Pharmaceutical Efficiency RTU Alliance Operational Risk Sterile Packaging
PRESS RELEASE published on 09/26/2024 at 12:30, 1 month 25 days ago SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” SCHOTT Pharma, Gerresheimer, and Stevanato Group form Alliance for RTU, advancing ready-to-use containers for pharmaceutical manufacturing efficiency and patient safety SCHOTT Pharma Gerresheimer Pharmaceutical Manufacturing Stevanato Group Alliance For RTU
BRIEF published on 09/05/2024 at 07:05, 2 months 16 days ago SCHOTT Pharma cotée au MDAX pour la première fois Bourse De Francfort Objectifs De Croissance Confiance Du Marché Inclusion MDAX Confinement Des Drogues
BRIEF published on 09/05/2024 at 07:05, 2 months 16 days ago SCHOTT Pharma Listed on MDAX for the First Time Frankfurt Stock Exchange Growth Targets Market Confidence MDAX Inclusion Drug Containment
PRESS RELEASE published on 09/05/2024 at 07:00, 2 months 16 days ago Promotion for SCHOTT Pharma: Listed on the MDAX for the first time SCHOTT Pharma AG & Co. KGaA to be included in the MDAX index, marking a significant milestone. Company continues to expand and strengthen market position Market Position SCHOTT Pharma Growth Targets MDAX Share Listing
BRIEF published on 08/29/2024 at 07:05, 2 months 23 days ago SCHOTT Pharma Delivers Strong Third Quarter Results and Raises FY 2024 Revenue Guidance Innovation Revenue Growth EBITDA Margin High-value Solutions Expansion Projects
BRIEF published on 08/29/2024 at 07:05, 2 months 23 days ago SCHOTT Pharma publie de solides résultats au troisième trimestre et relève ses prévisions de chiffre d'affaires pour l'exercice 2024 Innovation Croissance Des Revenus Marge D'EBITDA Des Solutions À Forte Valeur Ajoutée Projets D'agrandissement
PRESS RELEASE published on 08/29/2024 at 07:00, 2 months 23 days ago SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance SCHOTT Pharma reports strong Q3 results with 21% revenue growth, EBITDA margin of 28.2%, and raises FY 2024 revenue guidance. Strategic focus on innovation and growth projects Innovation Revenue Growth FY 2024 Guidance SCHOTT Pharma Q3 Results
BRIEF published on 08/08/2024 at 16:25, 3 months 12 days ago SCHOTT Pharma Aligns Climate Actions with Paris Agreement Goals Decarbonization Climate Action Green Electricity GHG Emissions Paris Agreement
Published on 11/21/2024 at 12:00, 33 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 33 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 3 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 30 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 33 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 18 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 3 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 32 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 25 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 13 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
